AMGNvsUTHR
Amgen IncvsUnited Therapeutics Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Amgen Inc
$348.62
+6.70%
United Therapeutics Corp
$572.85
+15.96%
60-day price, rebased to 100
Round-by-round
Valuation upside
-41.60% vs -10.40% to DCF fair value
Balance-sheet strength
Altman Z 1.78 vs 20.69
Fundamental quality
Piotroski 8.00 vs 7.00 (of 9)
Growth + margins
Rule-of-40 32.00 vs 43.10
60-day momentum
+1.97% vs +22.59% price return
Market-cap liquidity
$188.8B vs $23.1B
Verdict
Across6categories,UTHRtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onAMGNorUTHR
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.